Bridgeway Capital Management, LLC Iridex Corp Transaction History

Bridgeway Capital Management, LLC

$4.14 Billion
Q2 2024

A detailed history of Bridgeway Capital Management, LLC transactions in Iridex Corp stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 77,100 shares of IRIX stock, worth $107,168. This represents 0.0% of its overall portfolio holdings.

Number of Shares

77,100

Previous 77,100 -0.0%

Holding current value

$107,168

Previous $229,000 27.51%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.33 - $2.54 $301,777 - $576,326	-226,900 Reduced 74.64%	77,100 $195,000
Q2 2023 Aug 14, 2023	SELL	$1.76 - $2.43 $44,000 - $60,750	-25,000 Reduced 7.6%	304,000 $659,000
Q1 2023 May 15, 2023	SELL	$2.0 - $2.46 $30,800 - $37,884	-15,400 Reduced 4.47%	329,000 $667,000
Q2 2022 Aug 15, 2022	BUY	$2.48 - $4.66 $62,000 - $116,500	25,000 Added 7.83%	344,400 $885,000
Q4 2021 Feb 14, 2022	BUY	$5.62 - $9.37 $83,176 - $138,676	14,800 Added 4.86%	319,400 $1.95 Million
Q3 2021 Nov 15, 2021	BUY	$6.29 - $7.98 $254,116 - $322,392	40,400 Added 15.29%	304,600 $2.33 Million
Q2 2021 Aug 16, 2021	BUY	$6.67 - $9.2 $319,493 - $440,679	47,900 Added 22.15%	264,200 $1.87 Million
Q1 2021 May 17, 2021	BUY	$2.18 - $7.71 $163,064 - $576,708	74,800 Added 52.86%	216,300 $1.46 Million
Q4 2020 Feb 16, 2021	BUY	$1.62 - $2.91 $97,200 - $174,600	60,000 Added 73.62%	141,500 $355,000
Q2 2018 Aug 14, 2018	BUY	$5.33 - $7.24 $186,017 - $252,676	34,900 Added 74.89%	81,500 $553,000
Q1 2018 May 15, 2018	SELL	$5.72 - $8.28 $117,260 - $169,740	-20,500 Reduced 30.55%	46,600 $267,000
Q3 2017 Nov 14, 2017	BUY	$8.19 - $10.25 $549,549 - $687,775	67,100	67,100 $629,000

Others Institutions Holding IRIX

# of Institutions

Shares Held

3.25M

Call Options Held

500

Put Options Held

61.3K

View Full List

About IRIDEX CORP

Ticker IRIX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 15,985,600
Market Cap $22.2M
Description
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...

More about IRIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Account

Bridgeway Capital Management, LLC Iridex Corp Transaction History